“These continue to be Radiometer and Leica Biosystems, our specialty diagnostics businesses for us that continue to grow in the high single-digit range.”

In context

“s our customer base of these in the mid-teens of both consumables, as well as equipment. Consumable lead times are shorter than equipment, no doubts about that. It is rare that you get a consumable order, especially on these larger sized ones, that book in the quarter and ship in the same quarter. It happens, but it's not really the nature of the business. The majority of the business is shipped in the quarter that comes out of backlog. At the margin, you'll get some orders and quick turns. Casey Woodring Got it. That's helpful. Then maybe just in the diagnostics business, can you just elaborate on updated expectations for Radiometer and Leica, and some of the more instrument-heavy focused businesses there, how you're thinking about the back half of the year? Thank you. Rainer M. Blair These continue to be Radiometer and Leica Biosystems, our specialty diagnostics businesses for us that continue to grow in the high single-digit range. We really like what we see there. Continued innovation, continued commercial excellence. I might add the StatLab acquisition that really strengthens Leica Biosystems offering across the entire workflow and provides leverage across that entire workflow. It's very compatible, StatLab, with the existing portfolio. It's 85% consumables. It's got great economics, and we expect that to grow high single digits here in the long term as well. Leica Biosystems and Radiometer are solidly into the high single digits here, and we believe that continues for the long term. Operator Thank you. We will take our last question from Patrick Donnelly with Citi. Please go ahead. Rainer M. Blair Morning, Patrick. Patrick Donnelly Hey, guys. Hey, Rainer. Thanks for taking the question. Maybe another one on th”